Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking

Ophthalmic Research

Volumn 29, Issue 6, 1997, Pages 421-428

  Plater, Michael L ^a   Goode, Derek ^a   Crabbe, M James C ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Ageing; Cataract; Crystallin; Glycation; Lens; Protein folding

Indexed keywords

ALPHA CRYSTALLIN; CYANIC ACID; FRUCTOSE 6 PHOSPHATE; GAMMA CRYSTALLIN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; RIBOSE PHOSPHATE;

ARTICLE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROCESSING;

EID: 0030859628     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000268043     Document Type: Article

References (30)

1. Harding JJ, Crabbe MJC: The lens: Development, proteins, metabolism and cataract: in Davson H (ed): The Eye. ed 3. London. Academic Press. 1984. vol lb. pp 207-492.
2. Cerami A, Crabbe MJC: Recent advances in ocular cataract research. Trends Pharm Sci 1986;7:271-274.
3. Monnier VM, Cerami A: Non-en-zymic browning in vivo. Science 1981:211:491-493.
4. Baynes JW: The role of oxidation in the Maillard reaction in vivo; in Ikan R (ed): The Maillard Reaction. Chichester, Wiley, 1996. pp 55-72.
5. Harding JJ, van Heyningen R: Drugs, including alcohol, that act as risk factors for cataract. Br J Ophthalmol 1988:72:809-814.
6. Goode D, Crabbe MJC: Medium effects and molecular stability in gamma crystallins. Exp Eye Res 1994: 59:629-632.
7. Goode D, Crabbe MJC: Modelling molecular stability in gamma B crys-tallin. Cornput Chem 1995; 19:65-74.
8. Cotlier E, Sharma YG: Aspirin and senile cataracts in rheumatoid arthritis. Lancet 1981;i:338-339.
9. Crompton M, Rixon KC, Harding JJ: Aspirin prevents carbamylation of lens proteins. Exp Eye Res 1985; 40:297-311.
10. Ajiboyc R, Harding JJ: The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione. Exp Eye Res 1989:49: 31-41.
11. Huby R, Harding JJ: Non-enzymic glycosylation (glycation) of lens proteins. Exp Eye Res 1988;47:53-59.
12. Swanty MS, Abraham EC: Inhibition of lens crystallin glycation. Invest Opthalmol Vis Sci 1989;30: 1120-1126.
13. Rao GN, Cotlier E: Aspirin prevents the non-enzymic glycosylation and carbamylation of human eye lens crystallins in vitro. Biochem Bio-phys Res Commun 1989:151:991-996.
14. Blakytny R, Harding JJ: Prevention of cataract in diabetic rats by aspirin. paracetamol and ibuprofen. Exp Eye Res 1992;54:509-518.
15. Raza K, Harding JJ: Non-enzymic modification of lens proteins by glucose and fructose: Effects of ibupro-fcn. Exp Eye Res 1991;52:205-212.
16. Roberts KA, Harding JJ: Ibuprofen. a putative anti-cataract drug. Exp Eye Res 1990:50:157-164.
17. Horwitz J: Alpha crystallin behaves as a molecular chaperone. Proc Natl Acad Sci USA 1992:89:10449-10453.
18. Plater ML, Goode D, Crabbe MJC: Effects of site-directed mutations on the chaperone-like activity of alpha-B cry stallin. J Biol Chem 1996.271: 28558-28566.
19. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T.I. Nature 1970;227:680-685.
20. Shaw SM, Crabbe MJC: Monitoring the progress of non-cnzymatic glycation in vitro. Int J Peptide Protein Res 1994;44:594-602.
21. Ortwerth BJ, Olessen PR, Sharma KK, Prabhakarum M: Chemical modification of alpha crystallins. Exp Eye Res 1993;56:107-114.
22. Nagaraj RH, Sell DR, Prabhakarum M, Ortwerth B, Monnier V: High correlation between pcntosidinc protein cross-links and pigmentation implicates ascorbate oxidation in human lens senescence and cata-ractogenesis. Proc Natl Acad Sci USA 1991;88:10257-10261.
23. Vasan S, Zhang X, Zhang X, Kapur-niotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terleeky I, Bucala R, Cerami A, Egan J, Ulrich P: An agent cleaving glucose-derived protein cross-links in vitro and in vivo. Nature 1996:382:275-278.
24. Ganea E, Harding JJ: Molecular chaperones protect against glyca-tion-induced inactivation of glu-cose-6-phosphate dehydrogenase. EurJ Biochem 1995,231:181-185.
25. Cherian M, Abraham EC: Decreased molecular chaperone property of alpha B crystallins due to post-translational modification. Biochem Biophys Res Commun 1995;208:675-679.
26. Carver JA, Guerreiro N, Nicholls KA, Truscott RJW: On the interaction of alpha-crystallin with unfolded protein. Biochim Biophys Acta 1995;1252:251-260.
27. Rao PY, Huang Q-L, Horwitz J, Ziglcer JS: Evidence that alpha crystallin prevents non-specific protein aggregation in the intact lens. Biochim Biophys Acta 1995; 1245:439-447.
28. Chitpinityol S, Goode D, Crabbe MJC: Docs a-crystallin chaperone prochymosin folding? in Gcisow MJ (ed): Perspectives on Protein Engineering. Montpellier, Biodigm Ltd. 1996.
29. Chitpinityol S, Crabbe MJC: Chymosin and aspartic proteases. Food Chem 1997 (in press).
30. Shyadehi AZ. Harding JJ: Investigations of ibuprofen and paracetamol binding to lens proteins. Biochem Pharmacol 1991;42:2077-2084.